Journal Information
Issue
Vol. 40. Issue 2.
Pages 71-146 (February 2021)
Issue in English
Artigos originais
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial
Guy F.A. Prado Jr, Alexandre A.C. Abizaid, George C. Meireles, Rogério Sarmento-Leite, Mauricio Prudente, Marcelo Cantarelli, Adriano D. Dourado, Jose Mariani Jr, Marco A. Perin, Costantino Costantini, Ricardo Costa, J. Ribamar Costa, Daniel Chamie, Carlos M. Campos, Expedito E. Ribeiro, Pedro A. Lemos
Rev Port Cardiol. 2021;40:71-6
Open access
Artigos Originais
Comentário editorial
The third generation of drug-eluting stents: Reassuring data while we wait for the next one
Sergio Bravo Baptista
Rev Port Cardiol. 2021;40:77-80
Open access
Five years of Stent for Life in Portugal
Hélder Pereira, Rita Calé, Ernesto Pereira, Sofia Mello, Sílvia Vitorino, Pedro Jerónimo de Sousa, Sílvia Monteiro, Fausto J. Pinto, Raquel Ramos, Pedro Coelho dos Santos, João Ferreira, João Silveira, João Morais
Rev Port Cardiol. 2021;40:81-90
Open access
Artigos Originais
Comentário editorial
Convergent initiatives to change the current situation
Rui Cruz Ferreira
Rev Port Cardiol. 2021;40:91-3
Open access
Long-term outcomes after radiofrequency catheter ablation of the atrioventricular node: The experience of a Portuguese tertiary center
Ana Mosalina Manuel, João Almeida, Paulo Fonseca, Joel Monteiro, Cláudio Guerreiro, Ana Raquel Barbosa, Pedro Teixeira, José Ribeiro, Elisabeth Santos, Filipa Rosas, Adelaide Dias, Daniel Caeiro, Olga Sousa, Madalena Teixeira, Marco Oliveira, Helena Gonçalves, João Primo, Pedro Braga
Rev Port Cardiol. 2021;40:95-103
Open access
Artigos Originais
Comentário editorial
Pace and ablate: The ultimate treatment for atrial fibrillation?
Pedro Carmo
Rev Port Cardiol. 2021;40:105-7
Open access
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
Nuno Marques, Laetitia Gerlier, Mafalda Ramos, Helder Pereira, Sérgia Rocha, Ana Catarina Fonseca, Ana André, Ricardo Melo, Eduard Sidelnikov
Rev Port Cardiol. 2021;40:109-15
Open access
Artigos Originais
Comentário editorial
Indirect costs associated with cardiovascular events in Portugal
Miguel Gouveia
Rev Port Cardiol. 2021;40:117-8
Open access
Registo Nacional de Eletrofisiologia Cardíaca 2017‐2018
Nuno Cortez‐Dias, Pedro Silva Cunha, Francisco Moscoso Costa, Daniel Bonhorst, Mário M. Oliveira
Rev Port Cardiol. 2021;40:119-29
Open access
Artigos Originais
Comentário editorial
Portuguese electrophysiology: Consistent development
Francisco Bello Morgado
Rev Port Cardiol. 2021;40:131-2
Open access
Pequena comunicação
A preliminary identification of PIN1 SNP linkage in patients with coronary heart disease from Handan, China
Jing-Zhang Wang, Yu-Hua Zhang, Jing Bai, Wen-Tao Du, Xiang-Yang Zhang
Rev Port Cardiol. 2021;40:133-9
Open access
Caso clínico
Left ventricular pacing with a temporary pacemaker: Case report
Marta Tavares-Silva, Carla de Sousa, Vítor Araújo, Luís Adão, Gonçalo Pestana, Roberto Pinto, Filipe Macedo, Maria Júlia Maciel
Rev Port Cardiol. 2021;40:141.e1-141.e4
Open access
Imagem em cardiologia
Late challenges after full plastic jacket in spontaneous coronary dissection
Patrícia Marques-Alves, Manuel Oliveira-Santos, João Silva Marques, Lino Gonçalves
Rev Port Cardiol. 2021;40:143-4
Open access
Carta ao editor
Idiomas
Revista Portuguesa de Cardiologia (English edition)

Subscribe to our newsletter

en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.